These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 27437663)
21. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age. Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385 [TBL] [Abstract][Full Text] [Related]
22. [Therapy and risk-stratification in hypertrophic cardiomyopathy--a current survey]. Reith S; Klues HG Z Kardiol; 2003 Apr; 92(4):283-93. PubMed ID: 12707787 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426 [TBL] [Abstract][Full Text] [Related]
24. Importance and feasibility of creating hypertrophic cardiomyopathy centers in developing countries: the experience in India. Maron BJ Am J Cardiol; 2015 Jul; 116(2):332-4. PubMed ID: 25983127 [TBL] [Abstract][Full Text] [Related]
25. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ; Spirito P J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577 [TBL] [Abstract][Full Text] [Related]
27. [Interventional treatment in hypertrophic cardiomyopathy]. Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098 [TBL] [Abstract][Full Text] [Related]
28. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410 [TBL] [Abstract][Full Text] [Related]
30. Can sudden cardiac death be prevented? Maron BJ Cardiovasc Pathol; 2010; 19(6):329-35. PubMed ID: 20378375 [TBL] [Abstract][Full Text] [Related]
31. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy]. Sadoul N; de Chillou C; Aliot E; McKenna WJ Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160 [TBL] [Abstract][Full Text] [Related]
33. Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America? Östman-Smith I; Rossano JW; Shaddy RE Curr Opin Cardiol; 2013 Mar; 28(2):130-8. PubMed ID: 23348710 [TBL] [Abstract][Full Text] [Related]
34. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. O'Mahony C; Lambiase PD; Quarta G; Cardona M; Calcagnino M; Tsovolas K; Al-Shaikh S; Rahman SM; Arnous S; Jones S; McKenna W; Elliott P Heart; 2012 Jan; 98(2):116-25. PubMed ID: 21757459 [TBL] [Abstract][Full Text] [Related]
36. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery. Magnusson P; Gadler F; Liv P; Mörner S J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879 [TBL] [Abstract][Full Text] [Related]
37. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications. Vriesendorp PA; Schinkel AF; Van Cleemput J; Willems R; Jordaens LJ; Theuns DA; van Slegtenhorst MA; de Ravel TJ; ten Cate FJ; Michels M Am Heart J; 2013 Sep; 166(3):496-502. PubMed ID: 24016499 [TBL] [Abstract][Full Text] [Related]
38. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy. Cotiga D; Ehlert F; Sherrid M Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272 [TBL] [Abstract][Full Text] [Related]
39. New trends in treatment of hypertrophic cardiomyopathy. Hagège AA; Desnos M Arch Cardiovasc Dis; 2009 May; 102(5):441-7. PubMed ID: 19520330 [TBL] [Abstract][Full Text] [Related]